{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:04:23Z","timestamp":1789459463416,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.7759\/cureus.116255","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:19:33Z","timestamp":1789456773000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Sugammadex and Neostigmine for Reversal of Vecuronium-Induced Neuromuscular Blockade in Pediatric Patients: A Prospective Randomized Study"],"prefix":"10.7759","author":[{"given":"Neha","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhaker","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Dhiraaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.17085\/apm.23158","article-title":"Neuromuscular blockade monitoring in pediatric patients","volume":"19","author":"Ozgen ZS","year":"2024","unstructured":"Ozgen ZS. Neuromuscular blockade monitoring in pediatric patients. Anesth Pain Med. 2024, 19:S12-S24. 10.17085\/apm.23158","journal-title":"Anesth Pain Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aep093","article-title":"Reversal of neuromuscular block","volume":"103","author":"Srivastava A","year":"2009","unstructured":"Srivastava A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth. 2009, 103:115-129. 10.1093\/bja\/aep093","journal-title":"Br J Anaesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0259-1162.123211","article-title":"Sugammadex: a revolutionary drug in neuromuscular pharmacology","volume":"7","author":"Nag K","year":"2013","unstructured":"Nag K, Singh DR, Shetti AN, Kumar H, Sivashanmugam T, Parthasarathy S. Sugammadex: a revolutionary drug in neuromuscular pharmacology. Anesth Essays Res. 2013, 7:302-306. 10.4103\/0259-1162.123211","journal-title":"Anesth Essays Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012763","article-title":"Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults","volume":"8","author":"Hristovska AM","year":"2017","unstructured":"Hristovska AM, Duch P, Allingstrup M, Afshari A. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev. 2017, 8:CD012763. 10.1002\/14651858.CD012763","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/njms.njms_210_23","article-title":"Reversing rocuronium-induced neuromuscular block by sugammadex: new safety horizon for Indian population","volume":"16","author":"Kumar P","year":"2025","unstructured":"Kumar P, Kaur K, Singhal SK, Vashishth S, Manohar M, Bangarwa N. Reversing rocuronium-induced neuromuscular block by sugammadex: new safety horizon for Indian population. Natl J Maxillofac Surg. 2025, 16:77-82. 10.4103\/njms.njms_210_23","journal-title":"Natl J Maxillofac Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijca.2025.057","article-title":"A comparative study on the efficacy of sugammadex (2mg\/kg) in reversing rocuronium- and vecuronium-induced neuromuscular blockade in elective neurosurgery patients.","volume":"12","author":"Mehta S","year":"2025","unstructured":"Mehta S, Singh ND, Pawar KS, Magar AN.. A comparative study on the efficacy of sugammadex (2mg\/kg) in reversing rocuronium- and vecuronium-induced neuromuscular blockade in elective neurosurgery patients.. Indian J Clin Anaesth. 2025, 12:365-372. 10.18231\/j.ijca.2025.057","journal-title":"Indian J Clin Anaesth"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005533","article-title":"Sugammadex versus neostigmine for reversal of rocuronium neuromuscular block in patients having catheter-based neurointerventional procedures: a randomized trial","volume":"132","author":"Farag E","year":"2021","unstructured":"Farag E, Rivas E, Bravo M, et al.. Sugammadex versus neostigmine for reversal of rocuronium neuromuscular block in patients having catheter-based neurointerventional procedures: a randomized trial. Anesth Analg. 2021, 132:1666-1676. 10.1213\/ANE.0000000000005533","journal-title":"Anesth Analg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004587","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"14","author":"Hopewell S","year":"2025","unstructured":"Hopewell S, Chan AW, Collins GS, et al.. CONSORT 2025 statement: updated guideline for reporting randomised trials. PLoS Med. 2025, 14:e1004587. 10.1371\/journal.pmed.1004587","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56408","article-title":"The incidence of residual neuromuscular block in pediatrics: a prospective, pragmatic, multi-institutional cohort study","volume":"16","author":"Faulk DJ","year":"2024","unstructured":"Faulk DJ, Karlik JB, Strupp KM, et al.. The incidence of residual neuromuscular block in pediatrics: a prospective, pragmatic, multi-institutional cohort study. Cureus. 2024, 16:e56408. 10.7759\/cureus.56408","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/pan.14370","article-title":"Sugammadex for reversal of neuromuscular blockade in pediatric patients: results from a phase IV randomized study","volume":"32","author":"Voss T","year":"2022","unstructured":"Voss T, Wang A, DeAngelis M, et al.. Sugammadex for reversal of neuromuscular blockade in pediatric patients: results from a phase IV randomized study. Paediatr Anaesth. 2022, 32:436-445. 10.1111\/pan.14370","journal-title":"Paediatr Anaesth"},{"key":"ref11","article-title":"Comparison of reversal and adverse effects of sugammadex and combination of anticholinergic-anticholinesterase agents in pediatric patients","volume":"19","author":"Ozg\u00fcn C","year":"2014","unstructured":"Ozg\u00fcn C, Cakan T, Baltac\u0131 B, Ba\u015far H. Comparison of reversal and adverse effects of sugammadex and combination of anticholinergic-anticholinesterase agents in pediatric patients. J Res Med Sci. 2014, 19:762-768.","journal-title":"J Res Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12868","article-title":"A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children","volume":"61","author":"Ammar AS","year":"2017","unstructured":"Ammar AS, Mahmoud KM, Kasemy ZA. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children. Acta Anaesthesiol Scand. 2017, 61:374-380. 10.1111\/aas.12868","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004678","article-title":"Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: a systematic review and meta-analysis","volume":"95","author":"Won YJ","year":"2016","unstructured":"Won YJ, Lim BG, Lee DK, Kim H, Kong MH, Lee IO. Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: a systematic review and meta-analysis. Medicine. 2016, 95:e4678. 10.1097\/MD.0000000000004678","journal-title":"Medicine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/pan.13171","article-title":"Current evidence for the use of sugammadex in children","volume":"27","author":"Tobias JD","year":"2017","unstructured":"Tobias JD. Current evidence for the use of sugammadex in children. Paediatr Anaesth. 2017, 27:118-125. 10.1111\/pan.13171","journal-title":"Paediatr Anaesth"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318194caaa","article-title":"Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients","volume":"110","author":"Plaud B","year":"2009","unstructured":"Plaud B, Meretoja O, Hofmockel R, et al.. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology. 2009, 110:284-294. 10.1097\/ALN.0b013e318194caaa","journal-title":"Anesthesiology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjan.2014.03.001","article-title":"Sugammadex versus neostigmine in pediatric patients: a prospective randomized study","volume":"64","author":"Kara T","year":"2014","unstructured":"Kara T, Ozbagriacik O, Turk HS, et al.. Sugammadex versus neostigmine in pediatric patients: a prospective randomized study. Rev Bras Anestesiol. 2014, 64:400-405. 10.1016\/j.bjan.2014.03.001","journal-title":"Rev Bras Anestesiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/1658-354X.154696","article-title":"Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients","volume":"9","author":"Ghoneim AA","year":"2015","unstructured":"Ghoneim AA, El Beltagy MA. Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients. Saudi J Anaesth. 2015, 9:247-252. 10.4103\/1658-354X.154696","journal-title":"Saudi J Anaesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/aer.aer_139_21","article-title":"Recovery profile of sugammadex versus neostigmine in pediatric patients undergoing cardiac catheterization: a randomized double-blind study","volume":"15","author":"Saber HI","year":"2021","unstructured":"Saber HI, Mousa SA, AbouRezk AR, Zaglool A. Recovery profile of sugammadex versus neostigmine in pediatric patients undergoing cardiac catheterization: a randomized double-blind study. Anesth Essays Res. 2021, 15:272-278. 10.4103\/aer.aer_139_21","journal-title":"Anesth Essays Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2017.11.003","article-title":"Cardiac arrest following anaphylaxis induced by sugammadex in a regional hospital","volume":"44","author":"Obara S","year":"2018","unstructured":"Obara S, Kurosawa S, Honda J, Oishi R, Iseki Y, Murakawa M. Cardiac arrest following anaphylaxis induced by sugammadex in a regional hospital. J Clin Anesth. 2018, 44:62-63. 10.1016\/j.jclinane.2017.11.003","journal-title":"J Clin Anesth"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-22.5.378","article-title":"Bradycardia in a pediatric heart transplant recipient: is it the sugammadex?","volume":"22","author":"King A","year":"2017","unstructured":"King A, Naguib A, Tobias JD. Bradycardia in a pediatric heart transplant recipient: is it the sugammadex?. J Pediatr Pharmacol Ther. 2017, 22:378-381. 10.5863\/1551-6776-22.5.378","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.03.003","article-title":"Sugammadex-induced bradycardia and asystole: how great is the risk?","volume":"121","author":"Hunter JM","year":"2018","unstructured":"Hunter JM, Naguib M. Sugammadex-induced bradycardia and asystole: how great is the risk?. Br J Anaesth. 2018, 121:8-12. 10.1016\/j.bja.2018.03.003","journal-title":"Br J Anaesth"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005872","article-title":"Association of sugammadex or neostigmine with major postoperative pulmonary complications in children","volume":"135","author":"Beltran RJ","year":"2022","unstructured":"Beltran RJ, Mpody C, Nafiu OO, Tobias JD. Association of sugammadex or neostigmine with major postoperative pulmonary complications in children. Anesth Analg. 2022, 135:1041-1047. 10.1213\/ANE.0000000000005872","journal-title":"Anesth Analg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000002357","article-title":"2025 ESAIC and ESPA Guidelines on neuromuscular block in anaesthetised children: indications, monitoring and reversal","volume":"43","author":"Veyckemans F","year":"2026","unstructured":"Veyckemans F, Debouche S, Kaufmann J, et al.. 2025 ESAIC and ESPA Guidelines on neuromuscular block in anaesthetised children: indications, monitoring and reversal. Eur J Anaesthesiol. 2026, 43:295-323. 10.1097\/EJA.0000000000002357","journal-title":"Eur J Anaesthesiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/526499-comparison-of-sugammadex-and-neostigmine-for-reversal-of-vecuronium-induced-neuromuscular-blockade-in-pediatric-patients-a-prospective-randomized-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:19:34Z","timestamp":1789456774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/526499-comparison-of-sugammadex-and-neostigmine-for-reversal-of-vecuronium-induced-neuromuscular-blockade-in-pediatric-patients-a-prospective-randomized-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.116255","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}